BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miwa J, Echizen H, Matsueda K, Umeda N. Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits. Digestion. 2001;63:188-194. [PMID: 11351146 DOI: 10.1159/000051888] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Luo M, Zhuang X, Tian Z, Xiong L. Alterations in short-chain fatty acids and serotonin in irritable bowel syndrome: a systematic review and meta-analysis. BMC Gastroenterol 2021;21:14. [PMID: 33407171 DOI: 10.1186/s12876-020-01577-5] [Reference Citation Analysis]
2 Balmus IM, Ciobica A, Cojocariu R, Luca AC, Gorgan L. Irritable Bowel Syndrome and Neurological Deficiencies: Is There A Relationship? The Possible Relevance of the Oxidative Stress Status. Medicina (Kaunas) 2020;56:E175. [PMID: 32295083 DOI: 10.3390/medicina56040175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Tian XY, Bian ZX, Hu XG, Zhang XJ, Liu L, Zhang H. Electro-acupuncture attenuates stress-induced defecation in rats with chronic visceral hypersensitivity via serotonergic pathway. Brain Res. 2006;1088:101-108. [PMID: 16650387 DOI: 10.1016/j.brainres.2006.03.014] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
4 Hudon Thibeault AA, Sanderson JT, Vaillancourt C. Serotonin-estrogen interactions: What can we learn from pregnancy? Biochimie 2019;161:88-108. [PMID: 30946949 DOI: 10.1016/j.biochi.2019.03.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
5 Minderhoud IM, Oldenburg B, Schipper ME, ter Linde JJ, Samsom M. Serotonin synthesis and uptake in symptomatic patients with Crohn’s disease in remission. Clin Gastroenterol Hepatol. 2007;5:714-720. [PMID: 17481962 DOI: 10.1016/j.cgh.2007.02.013] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
6 Bian ZX, Zhang M, Han QB, Xu HX, Sung JJ. Analgesic effects of JCM-16021 on neonatal maternal separation-induced visceral pain in rats. World J Gastroenterol. 2010;16:837-845. [PMID: 20143462 DOI: 10.3748/wjg.v16.i7.837] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
7 Jia Z, Chen A, Bao F, He M, Gao S, Xu J, Zhang X, Niu P, Wang C. Effect of nisin on microbiome-brain-gut axis neurochemicals by Escherichia coli -induced diarrhea in mice. Microbial Pathogenesis 2018;119:65-71. [DOI: 10.1016/j.micpath.2018.04.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
8 Öhman L, Törnblom H, Simrén M. Crosstalk at the mucosal border: importance of the gut microenvironment in IBS. Nat Rev Gastroenterol Hepatol 2015;12:36-49. [DOI: 10.1038/nrgastro.2014.200] [Cited by in Crossref: 106] [Cited by in F6Publishing: 94] [Article Influence: 15.1] [Reference Citation Analysis]
9 Zhu X, Liu Z, Qu H, Niu W, Gao L, Wang Y, Zhang A, Bai L. The effect and mechanism of electroacupuncture at LI11 and ST37 on constipation in a rat model. Acupunct Med 2016;34:194-200. [PMID: 26561562 DOI: 10.1136/acupmed-2015-010897] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 6.8] [Reference Citation Analysis]
10 Vahedi H, Merat S, Rashidioon A, Ghoddoosi A, Malekzadeh R. The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study. Aliment Pharmacol Ther. 2005;22:381-385. [PMID: 16128675 DOI: 10.1111/j.1365-2036.2005.02566.x] [Cited by in Crossref: 113] [Cited by in F6Publishing: 99] [Article Influence: 7.1] [Reference Citation Analysis]
11 Nellesen D, Chawla A, Oh DL, Weissman T, Lavins BJ, Murray CW. Comorbidities in patients with irritable bowel syndrome with constipation or chronic idiopathic constipation: a review of the literature from the past decade. Postgrad Med. 2013;125:40-50. [PMID: 23816770 DOI: 10.3810/pgm.2013.03.2640] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
12 Franke L, Schmidtmann M, Riedl A, van der Voort I, Uebelhack R, Mönnikes H. Serotonin transporter activity and serotonin concentration in platelets of patients with irritable bowel syndrome: effect of gender. J Gastroenterol. 2010;45:389-398. [PMID: 19997855 DOI: 10.1007/s00535-009-0167-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
13 Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol. 2010;1:97-105. [PMID: 21607147 DOI: 10.4291/wjgp.v1.i3.97.] [Reference Citation Analysis]
14 Zuo XL, Li YQ, Yang XZ, Guo M, Guo YT, Lu XF, Li JM, Desmond PV. Plasma and gastric mucosal 5-hydroxytryptamine concentrations following cold water intake in patients with diarrhea-predominant irritable bowel syndrome. J Gastroenterol Hepatol. 2007;22:2330-2337. [PMID: 18265445 DOI: 10.1111/j.1440-1746.2006.04772.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
15 Houghton LA, Atkinson W, Whitaker RP, Whorwell PJ, Rimmer MJ. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut. 2003;52:663-670. [PMID: 12692050 DOI: 10.1136/gut.52.5.663] [Cited by in Crossref: 115] [Cited by in F6Publishing: 122] [Article Influence: 6.4] [Reference Citation Analysis]
16 Liu YL, Chen Y, Fan WT, Cao P, Yan J, Zhao XZ, Dong WG, Huang WH. Mechanical Distension Induces Serotonin Release from Intestine as Revealed by Stretchable Electrochemical Sensing. Angew Chem Int Ed Engl 2020;59:4075-81. [PMID: 31829491 DOI: 10.1002/anie.201913953] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 17.0] [Reference Citation Analysis]
17 Franke L, Schewe H, Uebelhack R, Berghöfer A, Müller-oerlinghausen B. Platelet-5HT uptake and gastrointestinal symptoms in patients suffering from major depression. Life Sciences 2003;74:521-31. [DOI: 10.1016/j.lfs.2003.07.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
18 Fitzgerald P, Cassidy Eugene M, Clarke G, Scully P, Barry S, Quigley Eamonn MM, Shanahan F, Cryan J, Dinan Timothy G. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity. Neurogastroenterol Motil. 2008;20:1291-1297. [PMID: 18823288 DOI: 10.1111/j.1365-2982.2008.01195.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 5.2] [Reference Citation Analysis]
19 Crowell MD. Role of serotonin in the pathophysiology of the irritable bowel syndrome. Br J Pharmacol. 2004;141:1285-1293. [PMID: 15100164 DOI: 10.1038/sj.bjp.0705762] [Cited by in Crossref: 141] [Cited by in F6Publishing: 114] [Article Influence: 8.3] [Reference Citation Analysis]
20 Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA, Spiller RC. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol. 2005;3:349-357. [PMID: 15822040 DOI: 10.1016/s1542-3565(04)00726-8] [Cited by in Crossref: 222] [Cited by in F6Publishing: 108] [Article Influence: 13.9] [Reference Citation Analysis]
21 Hansen MB, Witte AB. The role of serotonin in intestinal luminal sensing and secretion. Acta Physiol (Oxf). 2008;193:311-323. [PMID: 18462271 DOI: 10.1111/j.1748-1716.2008.01870.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 73] [Article Influence: 6.7] [Reference Citation Analysis]
22 Käll E, Lindström E, Martinez V. The serotonin reuptake inhibitor citalopram does not affect colonic sensitivity or compliance in rats. European Journal of Pharmacology 2007;570:203-11. [DOI: 10.1016/j.ejphar.2007.05.032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
23 Shiotani A, Kusunoki H, Kimura Y, Ishii M, Imamura H, Tarumi K, Manabe N, Kamada T, Hata J, Haruma K. S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome. Dig Dis Sci. 2013;58:2314-2323. [PMID: 23595519 DOI: 10.1007/s10620-013-2677-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
24 Berardi RR. Safety and tolerability of tegaserod in irritable bowel syndrome management. J Am Pharm Assoc (2003) 2004;44:41-51. [PMID: 14965152 DOI: 10.1331/154434504322713228] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
25 Drisko J, Bischoff B, Hall M, McCallum R. Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. J Am Coll Nutr. 2006;25:514-522. [PMID: 17229899 DOI: 10.1080/07315724.2006.10719567] [Cited by in Crossref: 61] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
26 Shekhar C, Monaghan PJ, Morris J, Issa B, Whorwell PJ, Keevil B, Houghton LA. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology. 2013;145:749-757; quiz e13-4. [PMID: 23872499 DOI: 10.1053/j.gastro.2013.07.014] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 9.6] [Reference Citation Analysis]
27 Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R. New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther. 2004;20 Suppl 2:1-9. [PMID: 15335408 DOI: 10.1111/j.1365-2036.2004.02036.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 120] [Article Influence: 7.1] [Reference Citation Analysis]
28 Spiller R. Serotonin and GI clinical disorders. Neuropharmacology. 2008;55:1072-1080. [PMID: 18687345 DOI: 10.1016/j.neuropharm.2008.07.016] [Cited by in Crossref: 155] [Cited by in F6Publishing: 142] [Article Influence: 11.9] [Reference Citation Analysis]
29 Ozel RE, Hayat A, Wallace KN, Andreescu S. Effect of cerium oxide nanoparticles on intestinal serotonin in zebrafish. RSC Adv 2013;3:15298-309. [PMID: 24015353 DOI: 10.1039/C3RA41739E] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
30 Sikander A, Rana SV, Prasad KK. Role of serotonin in gastrointestinal motility and irritable bowel syndrome. Clinica Chimica Acta 2009;403:47-55. [DOI: 10.1016/j.cca.2009.01.028] [Cited by in Crossref: 135] [Cited by in F6Publishing: 116] [Article Influence: 11.3] [Reference Citation Analysis]
31 Costedio MM, Hyman N, Mawe GM. Serotonin and its role in colonic function and in gastrointestinal disorders. Dis Colon Rectum. 2007;50:376-388. [PMID: 17195902 DOI: 10.1007/s10350-006-0763-3] [Cited by in Crossref: 111] [Cited by in F6Publishing: 98] [Article Influence: 7.9] [Reference Citation Analysis]
32 Johanson JF. Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies. Neurogastroenterol Motil 2004;16:701-11. [PMID: 15601419 DOI: 10.1111/j.1365-2982.2004.00550.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
33 Kojima S, Tohei A, Ikeda M, Anzai N. An Endogenous Tachykinergic NK2/NK3 Receptor Cascade System Controlling the Release of Serotonin from Colonic Mucosa. Curr Neuropharmacol 2015;13:830-5. [PMID: 26630961 DOI: 10.2174/1570159x13666150825220524] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
34 Njagi J, Ball M, Best M, Wallace KN, Andreescu S. Electrochemical quantification of serotonin in the live embryonic zebrafish intestine. Anal Chem 2010;82:1822-30. [PMID: 20148518 DOI: 10.1021/ac902465v] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
35 Cui XF, Zhou WM, Yang Y, Zhou J, Li XL, Lin L, Zhang HJ. Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome. World J Gastroenterol. 2014;20:13521-13529. [PMID: 25309082 DOI: 10.3748/wjg.v20.i37.13521] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
36 Kojima S, Tohei A, Anzai N. A role for endogenous peptide YY in tachykinin NK(2) receptor-triggered 5-HT release from guinea pig isolated colonic mucosa. Br J Pharmacol 2012;167:1362-8. [PMID: 22758653 DOI: 10.1111/j.1476-5381.2012.02094.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
37 Bialowas S, Hagbom M, Nordgren J, Karlsson T, Sharma S, Magnusson KE, Svensson L. Rotavirus and Serotonin Cross-Talk in Diarrhoea. PLoS One 2016;11:e0159660. [PMID: 27459372 DOI: 10.1371/journal.pone.0159660] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
38 Pae CU, Masand PS, Ajwani N, Lee C, Patkar AA. Irritable bowel syndrome in psychiatric perspectives: a comprehensive review. Int J Clin Pract. 2007;61:1708-1718. [PMID: 17877658 DOI: 10.1111/j.1742-1241.2007.01409.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
39 Kim JJ, Wang H, Terc JD, Zambrowicz B, Yang QM, Khan WI. Blocking peripheral serotonin synthesis by telotristat etiprate (LX1032/LX1606) reduces severity of both chemical- and infection-induced intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2015;309:G455-65. [PMID: 26206858 DOI: 10.1152/ajpgi.00299.2014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
40 Linan-Rico A, Ochoa-Cortes F, Beyder A, Soghomonyan S, Zuleta-Alarcon A, Coppola V, Christofi FL. Mechanosensory Signaling in Enterochromaffin Cells and 5-HT Release: Potential Implications for Gut Inflammation. Front Neurosci 2016;10:564. [PMID: 28066160 DOI: 10.3389/fnins.2016.00564] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
41 Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL, Han SP. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol. 2007;13:6041-6047. [PMID: 18023097 DOI: 10.3748/wjg.13.6041] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
42 Prins A. The brain-gut interaction: the conversation and the implications. South African Journal of Clinical Nutrition 2016;24:8-14. [DOI: 10.1080/16070658.2011.11734373] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
43 Baker DE. Rationale for using serotonergic agents to treat irritable bowel syndrome. Am J Health Syst Pharm 2005;62:700-11; quiz 712-3. [PMID: 15790796 DOI: 10.1093/ajhp/62.7.700] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
44 Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol. 2010;1:97-105. [PMID: 21607147 DOI: 10.4291/wjgp.v1.i3.97] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 52] [Article Influence: 5.4] [Reference Citation Analysis]
45 Banskota S, Ghia JE, Khan WI. Serotonin in the gut: Blessing or a curse. Biochimie 2019;161:56-64. [PMID: 29909048 DOI: 10.1016/j.biochi.2018.06.008] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 10.7] [Reference Citation Analysis]
46 Aboumarzouk OM, Agarwal T, Antakia R, Shariff U, Nelson RL. Cisapride for intestinal constipation. Cochrane Database Syst Rev 2011;:CD007780. [PMID: 21249695 DOI: 10.1002/14651858.CD007780.pub2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
47 Garvin B, Wiley JW. The role of serotonin in irritable bowel syndrome: implications for management. Curr Gastroenterol Rep. 2008;10:363-368. [PMID: 18627647 DOI: 10.1007/s11894-008-0070-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
48 Fourie NH, Peace RM, Abey SK, Sherwin LB, Rahim-Williams B, Smyser PA, Wiley JW, Henderson WA. Elevated circulating miR-150 and miR-342-3p in patients with irritable bowel syndrome. Exp Mol Pathol. 2014;96:422-425. [PMID: 24768587 DOI: 10.1016/j.yexmp.2014.04.009] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 8.1] [Reference Citation Analysis]
49 Manocha M, Khan WI. Serotonin and GI Disorders: An Update on Clinical and Experimental Studies. Clin Transl Gastroenterol. 2012;3:e13. [PMID: 23238212 DOI: 10.1038/ctg.2012.8] [Cited by in Crossref: 105] [Cited by in F6Publishing: 88] [Article Influence: 11.7] [Reference Citation Analysis]
50 Manocha M, Shajib MS, Rahman MM, Wang H, Rengasamy P, Bogunovic M, Jordana M, Mayer L, Khan WI. IL-13-mediated immunological control of enterochromaffin cell hyperplasia and serotonin production in the gut. Mucosal Immunol 2013;6:146-55. [PMID: 22763407 DOI: 10.1038/mi.2012.58] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
51 Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology. 2006;130:34-43. [PMID: 16401466 DOI: 10.1053/j.gastro.2005.09.031] [Cited by in Crossref: 208] [Cited by in F6Publishing: 199] [Article Influence: 13.9] [Reference Citation Analysis]
52 Camilleri M. LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin. Neurogastroenterol Motil. 2011;23:193-200. [PMID: 21159063 DOI: 10.1111/j.1365-2982.2010.01643.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
53 Tack J, Broekaert D, Corsetti M, Fischler B, Janssens J. Influence of acute serotonin reuptake inhibition on colonic sensorimotor function in man. Aliment Pharmacol Ther. 2006;23:265-274. [PMID: 16393306 DOI: 10.1111/j.1365-2036.2006.02724.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
54 Kojima S, Tohei A, Ikeda M. Melatonin inhibits tachykinin NK₂ receptor-triggered 5-HT release from guinea pig isolated colonic mucosa. Br J Pharmacol 2011;162:1179-85. [PMID: 21091649 DOI: 10.1111/j.1476-5381.2010.01122.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
55 Mawe GM, Coates MD, Moses PL. Review article: intestinal serotonin signalling in irritable bowel syndrome. Aliment Pharmacol Ther. 2006;23:1067-1076. [PMID: 16611266 DOI: 10.1111/j.1365-2036.2006.02858.x] [Cited by in Crossref: 136] [Cited by in F6Publishing: 130] [Article Influence: 9.1] [Reference Citation Analysis]
56 Costedio MM, Coates MD, Brooks EM, Glass LM, Ganguly EK, Blaszyk H, Ciolino AL, Wood MJ, Strader D, Hyman NH. Mucosal serotonin signaling is altered in chronic constipation but not in opiate-induced constipation. Am J Gastroenterol. 2010;105:1173-1180. [PMID: 20010921 DOI: 10.1038/ajg.2009.683] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
57 Salem AE, Singh R, Ayoub YK, Khairy AM, Mullin GE. The gut microbiome and irritable bowel syndrome: State of art review. Arab J Gastroenterol. 2018;19:136-141. [PMID: 29935865 DOI: 10.1016/j.ajg.2018.02.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
58 Ropenga A, Combes O, Chapel A, Griffiths NM. Persistence of altered 5‐hydroxytryptamine turnover following hemibody X‐irradiation in the rat distal colon. International Journal of Radiation Biology 2009;80:399-411. [DOI: 10.1080/09553000410001702364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
59 Wang SH, Dong L, Luo JY, Gong J, Li L, Lu XL, Han SP. Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol. 2007;13:6041-6047. [PMID: 18023097 DOI: 10.3748/wjg.v13.45.6041] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 45] [Article Influence: 2.0] [Reference Citation Analysis]
60 Padhy SK, Sahoo S, Mahajan S, Sinha SK. Irritable bowel syndrome: Is it "irritable brain" or "irritable bowel"? J Neurosci Rural Pract 2015;6:568-77. [PMID: 26752904 DOI: 10.4103/0976-3147.169802] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
61 Bayer SB, Gearry RB, Drummond LN. Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function. Crit Rev Food Sci Nutr 2018;58:2432-52. [PMID: 28557573 DOI: 10.1080/10408398.2017.1327841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
62 Esmaili A, Nazir SF, Borthakur A, Yu D, Turner JR, Saksena S, Singla A, Hecht GA, Alrefai WA, Gill RK. Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression. Gastroenterology. 2009;137:2074-2083. [PMID: 19747920 DOI: 10.1053/j.gastro.2009.09.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.4] [Reference Citation Analysis]
63 Holzer P. Gastrointestinal pain in functional bowel disorders: sensory neurons as novel drug targets. Expert Opin Ther Targets. 2004;8:107-123. [PMID: 15102553 DOI: 10.1517/14728222.8.2.107] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
64 Liu Y, Chen Y, Fan W, Cao P, Yan J, Zhao X, Dong W, Huang W. Mechanical Distension Induces Serotonin Release from Intestine as Revealed by Stretchable Electrochemical Sensing. Angew Chem 2020;132:4104-10. [DOI: 10.1002/ange.201913953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
65 Julio-Pieper M, O'Mahony CM, Clarke G, Bravo JA, Dinan TG, Cryan JF. Chronic stress-induced alterations in mouse colonic 5-HT and defecation responses are strain dependent. Stress 2012;15:218-26. [PMID: 21875301 DOI: 10.3109/10253890.2011.607524] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
66 Zhao H, Bian X, Galligan JJ, Swain GM. Electrochemical measurements of serotonin (5-HT) release from the guinea pig mucosa using continuous amperometry with a boron-doped diamond microelectrode. Diamond and Related Materials 2010;19:182-5. [DOI: 10.1016/j.diamond.2009.10.004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
67 Camilleri M. Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea. Clin Gastroenterol Hepatol 2015;13:1051-7; quiz e61-2. [PMID: 25041862 DOI: 10.1016/j.cgh.2014.07.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
68 Camilleri M. Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes 2009;16:53-9. [PMID: 19115522 DOI: 10.1097/med.0b013e32831e9c8e] [Cited by in Crossref: 83] [Cited by in F6Publishing: 27] [Article Influence: 6.9] [Reference Citation Analysis]
69 McLaughlin J, Houghton LA. The rationale, efficacy and safety evidence for tegaserod in the treatment of irritable bowel syndrome. Expert Opin Drug Saf. 2006;5:313-327. [PMID: 16503751 DOI: 10.1517/14740338.5.2.313] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
70 Hansen MB. The enteric nervous system I: organisation and classification. Pharmacol Toxicol. 2003;92:105-113. [PMID: 12753424 DOI: 10.1034/j.1600-0773.2003.t01-1-920301.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 69] [Article Influence: 5.4] [Reference Citation Analysis]
71 Knecht LD, O'Connor G, Mittal R, Liu XZ, Daftarian P, Deo SK, Daunert S. Serotonin Activates Bacterial Quorum Sensing and Enhances the Virulence of Pseudomonas aeruginosa in the Host. EBioMedicine 2016;9:161-9. [PMID: 27333040 DOI: 10.1016/j.ebiom.2016.05.037] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
72 Jeyarajah S, Papagrigoriadis S. Review article: the pathogenesis of diverticular disease - current perspectives on motility and neurotransmitters: Review: neurotransmitters and diverticular disease. Alimentary Pharmacology & Therapeutics 2011;33:789-800. [DOI: 10.1111/j.1365-2036.2011.04586.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
73 Jeyarajah S, Akbar N, Moorhead J, Haji A, Banerjee S, Papagrigoriadis S. A clinicopathological study of serotonin of sigmoid colon mucosa in association with chronic symptoms in uncomplicated diverticulosis. Int J Colorectal Dis. 2012;27:1597-1605. [PMID: 22744736 DOI: 10.1007/s00384-012-1515-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
74 Kerckhoffs AP, ter Linde JJ, Akkermans LM, Samsom M. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine. Am J Physiol Gastrointest Liver Physiol. 2012;302:G1053-G1060. [PMID: 22323131 DOI: 10.1152/ajpgi.00153.2011] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 6.0] [Reference Citation Analysis]
75 Shi X, Hu Y, Zhang B, Li W, Chen JD, Liu F. Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation. JCI Insight 2021;6:150052. [PMID: 34138761 DOI: 10.1172/jci.insight.150052] [Reference Citation Analysis]
76 Zhu X, Shen W, Wang Y, Jaiswal A, Ju Z, Sheng Q. Nicotinamide adenine dinucleotide replenishment rescues colon degeneration in aged mice. Signal Transduct Target Ther 2017;2:17017. [PMID: 29263919 DOI: 10.1038/sigtrans.2017.17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
77 Camilleri M. Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms. J Physiol. 2014;592:2967-2980. [PMID: 24665101 DOI: 10.1113/jphysiol.2014.270892] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 8.3] [Reference Citation Analysis]
78 Spiller R. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol Motil. 2007;19 Suppl 2:25-31. [PMID: 17620085 DOI: 10.1111/j.1365-2982.2007.00965.x] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 6.4] [Reference Citation Analysis]
79 Bian ZX, Li Z, Huang ZX, Zhang M, Chen HL, Xu HX, Sung JJ. Unbalanced expression of protease-activated receptors-1 and -2 in the colon of diarrhea-predominant irritable bowel syndrome patients. J Gastroenterol. 2009;44:666-674. [PMID: 19430717 DOI: 10.1007/s00535-009-0058-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
80 Hansen MB. The enteric nervous system III: a target for pharmacological treatment. Pharmacol Toxicol 2003;93:1-13. [PMID: 12828568 DOI: 10.1034/j.1600-0773.2003.930101.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
81 Matricon J, Meleine M, Gelot A, Piche T, Dapoigny M, Muller E, Ardid D. Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther 2012;36:1009-31. [DOI: 10.1111/apt.12080] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 13.9] [Reference Citation Analysis]